The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine.

Autor: Gloviczki P; Division of Vascular and Endovascular Surgery, Gonda Vascular Center, Mayo Clinic, Rochester, MN. Electronic address: gloviczki.peter@mayo.edu., Lawrence PF; Division of Vascular and Endovascular Surgery, Department of Surgery, University of California, Los Angeles, CA., Wasan SM; Department of Medicine, University of North Carolina, Chapel Hill, Rex Vascular Specialists, UNC Health, Raleigh, NC., Meissner MH; Division of Vascular Surgery, University of Washington, Seattle, WA., Almeida J; Division of Vascular and Endovascular Surgery, University of Miami Miller School of Medicine, Miami, FL., Brown KR; Medical College of Wisconsin, Milwaukee, WI., Bush RL; John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX., Di Iorio M; South Austin Vein Center, Austin, TX., Fish J; Department of Medicine, Jobst Vascular Institute, University of Toledo, Toledo, OH., Fukaya E; Division of Vascular Surgery, Stanford University, Stanford, CA., Gloviczki ML; Department of Internal Medicine and Gonda Vascular Center, Rochester, MN., Hingorani A; NYU Brooklyn Medical Center, Brooklyn, NY., Jayaraj A; RANE Center for Venous and Lymphatic Diseases, Jackson, MS., Kolluri R; Heart and Vascular Service, OhioHealth Riverside Methodist Hospital, Columbus, OH., Murad MH; Evidence Based Practice Center, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN., Obi AT; University of Michigan, Ann Arbor, MI., Ozsvath KJ; Vascular Associates, St Peters Health Partners, Albany, NY., Singh MJ; University of Pittsburgh Medical Center, Pittsburgh, PA., Vayuvegula S; Vein Clinics of America, Plano, TX., Welch HJ; Lahey Hospital and Medical Center, Burlington, MA.
Jazyk: angličtina
Zdroj: Journal of vascular surgery. Venous and lymphatic disorders [J Vasc Surg Venous Lymphat Disord] 2024 Jan; Vol. 12 (1), pp. 101670. Date of Electronic Publication: 2023 Aug 29.
DOI: 10.1016/j.jvsv.2023.08.011
Abstrakt: The Society for Vascular Surgery, the American Venous Forum, and the American Vein and Lymphatic Society recently published Part I of the 2022 clinical practice guidelines on varicose veins. Recommendations were based on the latest scientific evidence researched following an independent systematic review and meta-analysis of five critical issues affecting the management of patients with lower extremity varicose veins, using the patients, interventions, comparators, and outcome system to answer critical questions. Part I discussed the role of duplex ultrasound scanning in the evaluation of varicose veins and treatment of superficial truncal reflux. Part II focuses on evidence supporting the prevention and management of varicose vein patients with compression, on treatment with drugs and nutritional supplements, on evaluation and treatment of varicose tributaries, on superficial venous aneurysms, and on the management of complications of varicose veins and their treatment. All guidelines were based on systematic reviews, and they were graded according to the level of evidence and the strength of recommendations, using the GRADE method. All ungraded Consensus Statements were supported by an extensive literature review and the unanimous agreement of an expert, multidisciplinary panel. Ungraded Good Practice Statements are recommendations that are supported only by indirect evidence. The topic, however, is usually noncontroversial and agreed upon by most stakeholders. The Implementation Remarks contain technical information that supports the implementation of specific recommendations. This comprehensive document includes a list of all recommendations (Parts I-II), ungraded consensus statements, implementation remarks, and best practice statements to aid practitioners with appropriate, up-to-date management of patients with lower extremity varicose veins.
Competing Interests: Disclosures J.F. is a paid speaker for Janssen Pharmaceuticals. M.L.G. has been paid a consulting fee by VitasupportMD and is on their advisory board. R.K. is a paid consultant for Abbott, Auxetics, Boston Scientific, Diachii Sankyo, Koya Medical, Medtronic, Penumbra, Philips, Surmodics, USA Therm, and VB Devices; is on DSMB/CEC for NAMSA and Prairie Education and Research Cooperative; and is on the Board of Trustees of The VIVA Foundation, the Society for Vascular Medicine, the American Vein and Lymphatic Society, and the Intersocietal Accreditation Council | Vascular Testing. A.T.O. is a primary investigator for preclinical research grants funded by Medtronic and SurModics. K.O. is an IAC executive board member, serves on the advisory board for Medtronic and Boston Scientific, is a speaker and ultrasound course host for Medtronic, is a speaker for Boston Scientific, a quality committee member of CDPHP, and PI for W. L. Gore & Associates, and for the Savve study for enVVeno Medical. S.W. is a paid speaker for Janssen Pharmaceuticals. P.G., P.F.L., M.H.M., M.M., J.A., K.B., R.L.B., M.D., M.S. E.F., A.H., A.J., S.V., and H.J.W. have no conflicts of interest.
(Copyright © 2023. Published by Elsevier Inc.)
Databáze: MEDLINE
Externí odkaz: